FDA Approves First Oral Cholesterol Pill | Washington DC News

FDA just approved Lipfendra, the first daily oral PCSK9 inhibitor pill, offering a game-changing alternative to weekly injections for lowering dangerous cholesterol levels. With dramatic reductions in LDL cholesterol seen in trials, this Merck drug could help millions combat heart disease — the top killer in the U.S. — by making treatment more convenient and accessible. Priced at $10.50 a day, it’s poised to reach patients soon and could become a vital new tool in the fight against strokes and heart attacks. Thank you to our sponsor Garrett Waller Performance: http://coaching.garrettwaller.com Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cbda289caf4b304e